Fingerprint
Dive into the research topics of 'A phase 2/3 multicenter, randomized, open-label study to compare the efficacy and safety of lenalidomide versus investigator's choice in patients with relapsed or refractory diffuse large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically